SGLT2 inhibitor tool developed to help doctors

A new tool has been developed to help doctors determine who would benefit the most from taking a class of type 2 diabetes drug. Sodium-glucose co-transporter-2 (SGLT2) inhibitors have been prescribed in the UK since 2013 and work by helping the kidneys t https://www.diabetes.co.uk/news/2018/jul/sglt2-inhibitor-tool-developed-to-help-doctors-97901737.html